Biopharmaceutical Characterisation and Testing

Product description

To help you meet your development milestones, we drive insight into the structure, physicochemical properties, potency and impurity profile of a biologic Expertise includes assessment of structure, heterogeneity, aggregation / biophysical characteristics, physicochemical properties, potency, stability and impurities. 
Our experts strategically deploy orthogonal protein analysis approaches (GLP/GMP) that address key molecular and biological characteristics (ICH Q6B) such as total protein quantity, key physicochemical properties, the extent of heterogeneity within a sample and across batches, the intricacies of the biomolecule’s structure including post-translational modifications (PTM), glycosylation, higher order structure and assessment of aggregation or degradation helping you to establish Critical Quality Attributes (CQAs) for your product and QC programs. 
Read more


Categories Biopharmaceuticals; BiopharmaceuticalsBiosimilars; Contract Services - Analytical & Lab ServicesQuality Control Testing
Sales markets Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied from United Kingdom

More products from Intertek Pharmaceutical Services

View all our products (81)

Products from other suppliers